增殖性玻璃红蛋白病变的致病机制和治疗进展:一篇综述
Jinhui Dai1, Xiaorong Zhou1, Haixia Bai1
1The First Clinical College of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, Changsha, China.
Medicine
|October 1, 2025
概括
增殖性视网膜病变 (PVR) 是手术后视网膜重新脱离的主要原因. 本综述探讨了PVR的使用情况.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 玻璃鼻外科 玻璃鼻外科
背景情况:
- 增殖性视网膜病变 (PVR) 是风湿性视网膜脱落手术失败的主要原因.
- 此外,PVR也是一种严重的并发症,在后部穿透眼部损伤后发生.
- 目前用于PVR的治疗药物有限,手术干预具有显著的复发率.
研究的目的:
- 为了提供一个全面的概述的增殖性玻璃红蛋白病变的发病因子.
- 审查目前和新兴的PVR治疗策略.
- 突出管理PVR的挑战,并确定未来研究的领域.
主要方法:
- 本综述综合了PVR现有文献中的信息.
- 确定并分析了关于PVR病原和治疗的关键研究.
- 该审查的重点是了解推动PVR发展的细胞和分子机制.
主要成果:
- PVR病原发生涉及复杂的细胞过程,包括细胞增殖,迁移和细胞外矩阵重塑.
- 目前的治疗主要涉及手术切除膜,以减轻视网膜的拉力.
- 尽管进行了手术,但PVR复发仍然是一个重大的临床挑战.
结论:
- 了解PVR病原体对于开发向疗法至关重要.
- 需要新的治疗策略来改善结果并降低复发率.
- 结合医疗和外科手术的多学科方法可以提供更好的PVR管理.
相关概念视频
01:27Open Angle Glaucoma: Treatment
963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
01:28Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K